Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA ...Middle East

GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration...

Hence then, the article about fermion announces ind approval of non addictive pain relief drug fz008 145 by china nmpa was published today ( Wednesday 10/01/2024 - 10:21 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA )

Also on site :

• Inside the epicenter of the Ebola outbreak in DRC as the virus spreads
• The Middle East war is testing the Gulf’s ambitions to become an AI hub
• Move over, seltzer. Non-carbonated drinks are taking the spotlight